Panacea Biotec Limited

BSE: 531349 NSE: PANACEABIO
Panacea Biotec Limited - life sciences in Lalru, Punjab, India. FY 2026 financials and compliance.
CIN L33117PB1984PLC022350 Incorporated 02 February 1984 ROC Chandigarh HQ Lalru, Punjab, India
Active Listed - NSE: PANACEABIO · BSE: 531349 Public Limited Company life sciences
Data last updated
Revenue · FY 2026
₹639.77 Cr
▲ 14.43% YoY
EBITDA · FY 2026
₹12.24 Cr
▲ 333.14% YoY
Net profit · FY 2026
-₹7.16 Cr
▲ 17.89% YoY
Authorised capital
₹122.34 Cr
Registered with MCA
Paid-up capital
₹22.26 Cr
Issued & subscribed
Open charges
₹739.69 Cr
Satisfied ₹3,545.32 Cr
Company age
42 yrs
Est. 1984
Employees · EPFO
1,173
Latest available

About Panacea Biotec Limited

Data last updated: 18 December 2025

Panacea Biotec Limited is a public limited company based in Lalru, Punjab, India. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 02 February 1984, the company has been in operation for over 42 years.

Registered with ROC Chandigarh under CIN L33117PB1984PLC022350. Listed on BSE: 531349 and NSE: PANACEABIO.

Capital: an authorised share capital of ₹122.34 Cr and a paid-up capital of ₹22.26 Cr. Formerly known as Panacea Drugs Ltd and Panacea Drugs Pvt Ltd. It is led by directors including Ambika Sharma and Harshet Jain.

Last AGM: 27 September 2024. Financial statements filed for year ended 31 March 2024. Office: Ambala – Chandigarh Highway, Lalru, Punjab, India – 140501.

As per the financials filed for FY 2024, the company reported a revenue of ₹384.51 Cr, a growth of 31.91% compared to the previous year.

The company has a workforce of approximately 1,173 employees as per the latest available data. Its group structure includes 2 subsidiaries and 1 joint venture.

As per MCA filings, the company has open charges of ₹739.69 Cr and satisfied charges of ₹3,545.32 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website panaceabiotec.com.

Company Details of Panacea Biotec Limited
CIN L33117PB1984PLC022350
Registration Number 022350
Incorporation Date 02 February 1984
ROC Chandigarh
Listing Status Listed (BSE: 531349, NSE: PANACEABIO)
Company Status Active
Date of Last AGM 27 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Key People
Sandeep Jain Managing Director Rajesh Jain Managing Director Harshet Jain Whole-Time Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    panaceabiotec.com
  • Social Media
    **************
  • Registered Address
    Ambala – Chandigarh Highway, Lalru, Punjab, India – 140501
  • Industry
    Life Sciences, Biotechnology
Company report
Panacea Biotec Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Panacea Biotec Limited report

Financials, compliance, directors, charges, ownership and filings for Panacea Biotec Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Panacea Biotec Limited

Panacea Biotec Limited has undergone 2 name changes throughout its history. The company was previously known as Panacea Drugs Ltd, and Panacea Drugs Pvt Ltd. The current legal name is Panacea Biotec Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Panacea Biotec Limited Current
Panacea Drugs Ltd Previous
Panacea Drugs Pvt Ltd Previous

CIN History of Panacea Biotec Limited

Panacea Biotec Limited has one previous CIN (Corporate Identification Number): U33117PB1984PLC022350. The current CIN is L33117PB1984PLC022350, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L33117PB1984PLC022350 Current
U33117PB1984PLC022350 Previous

Business Activity of Panacea Biotec Limited

Panacea Biotec Limited operates primarily in the manufacturing sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
********* Manufacturing ********* Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Panacea Biotec Limited

Panacea Biotec Limited is audited by Suresh Surana & Associates LLP (ICAI peer reviewed, certificate valid till 2028-03-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
Suresh Surana & Associates LLP (ICAI peer reviewed, certificate valid till 2028-03-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Panacea Biotec Limited

Panacea Biotec Limited is currently managed by 15 directors, with 30 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Ambika Sharma
Also directs: Panacea Biotec Limited, Kajaria Ceramics Limited, Indo Count Industries Limited and 5 more
Director 14 Feb 2024 2 Years 4 Months Current
Harshet Jain
Also directs: Panacea Biotec Limited, Md Next Life Sciences Llp
Whole-Time Director 14 Feb 2025 1 Years 4 Months Current
Mukul Gupta
Also directs: Panacea Biotec Limited
Director 01 Apr 2016 10 Years 3 Months Current
Rajender Pal Singh
Also directs: Panacea Biotec Limited, Top Cop Solutions Llp, Triveni Engineering And Industries Limited
Director 14 Feb 2025 1 Years 4 Months Current
Ankesh Jain
Also directs: Panacea Biotec Limited, Panacea Biotec Pharma Limited, Adveta Power Private Limited
Whole-Time Director 01 Apr 2016 10 Years 3 Months Current
Indra Kumar Sharma
Also directs: Panacea Biotec Limited
Person Incharge 13 Jun 2007 19 Years 0 Months Current
Showing 6 of 15 current directors. View all directors

Financials of Panacea Biotec Limited FY 2026 filings available

Panacea Biotec Limited reported revenue of ₹639.77 Cr (up 14.43% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹639.77 Cr ▲ 14.43%
Profit · FY 2026
-₹7.16 Cr ▲ 17.89%
EBITDA · FY 2026
₹12.24 Cr ▲ 333.14%
Revenue₹ Cr · Consolidated0250500750FY 2020: ₹544 Cr544FY 2020FY 2021: ₹625 Cr · +14.8% YoY625+14.8%FY 2021FY 2022: ₹661 Cr · +5.8% YoY661+5.8%FY 2022FY 2023: ₹460 Cr · -30.4% YoY460-30.4%FY 2023FY 2024: ₹559 Cr · +21.6% YoY559+21.6%FY 2024FY 2025: ₹559 Cr · +0% YoY559+0%FY 2025FY 2026: ₹640 Cr · +14.4% YoY640+14.4%FY 2026
Net Profit₹ Cr · Consolidated-50005001,0001,500FY 2020: ₹194 Cr (loss)-194FY 2020FY 2021: ₹148 Cr (loss) · +24% YoY-148FY 2021FY 2022: ₹1,078 Cr · +830% YoY1,078+830%FY 2022FY 2023: ₹34 Cr (loss) · -103.1% YoY-33.8FY 2023FY 2024: ₹2 Cr (loss) · +95.6% YoY-1.5FY 2024FY 2025: ₹9 Cr (loss) · -481.3% YoY-8.7FY 2025FY 2026: ₹7 Cr (loss) · +17.9% YoY-7.2FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0100200Q1'25: ₹116 Cr · -10.4% YoY116-10.4%Q1'25Q2'25: ₹147 Cr · +3% YoY147+3%Q2'25Q3'25: ₹163 Cr · +8.6% YoY163+8.6%Q3'25Q4'25: ₹133 Cr · -2.9% YoY133-2.9%Q4'25Q1'26: ₹167 Cr · +44.1% YoY167+44.1%Q1'26Q2'26: ₹141 Cr · -4.2% YoY141-4.2%Q2'26Q3'26: ₹165 Cr · +1% YoY165+1%Q3'26Q4'26: ₹167 Cr · +25.8% YoY167+25.8%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹639.77 Cr ₹559.09 Cr ₹559.17 Cr ₹459.95 Cr ₹661.23 Cr ₹624.81 Cr ₹544.06 Cr
Other Income ₹16.9 Cr ₹20.66 Cr ₹25.8 Cr ₹51.66 Cr ₹10.97 Cr ₹9.98 Cr ₹29.69 Cr
Total Income ₹656.67 Cr ₹579.75 Cr ₹584.97 Cr ₹511.61 Cr ₹672.2 Cr ₹634.79 Cr ₹573.75 Cr
Cost of Materials Consumed ₹290.24 Cr ₹214.07 Cr ₹210.46 Cr ₹211.03 Cr ₹281.25 Cr ₹168.48 Cr ₹179.3 Cr
Purchases of Stock-in-Trade ₹8.97 Cr ₹7.6 Cr ₹1.8 Cr ₹7.26 Cr ₹29.92 Cr ₹11.69 Cr ₹10.71 Cr
Changes in Inventories -₹18.73 Cr -₹22.13 Cr ₹17.86 Cr ₹34.37 Cr -₹48.97 Cr ₹24.46 Cr -₹33.22 Cr
Employee Benefit Expense ₹180.78 Cr ₹173.05 Cr ₹149.57 Cr ₹126.48 Cr ₹182.94 Cr ₹156.17 Cr ₹142.32 Cr
Finance Costs ₹6.05 Cr ₹3.88 Cr ₹3.58 Cr ₹4.44 Cr ₹180.84 Cr ₹185.34 Cr ₹173.98 Cr
Depreciation & Amortisation ₹33.06 Cr ₹34.81 Cr ₹36.71 Cr ₹39.12 Cr ₹43.66 Cr ₹45.6 Cr ₹43.22 Cr
Other Expenses ₹183.17 Cr ₹212.41 Cr ₹199.54 Cr ₹178.77 Cr ₹229.95 Cr ₹187.37 Cr ₹213.59 Cr
Total Expenses ₹683.54 Cr ₹623.69 Cr ₹619.52 Cr ₹601.47 Cr ₹899.59 Cr ₹779.11 Cr ₹729.9 Cr
Profit Before Exceptional Items & Tax -₹26.87 Cr -₹43.94 Cr -₹34.55 Cr -₹89.86 Cr -₹227.39 Cr -₹144.32 Cr -₹156.15 Cr
Exceptional Items ₹19.5 Cr ₹35.99 Cr ₹36.03 Cr ₹102.66 Cr ₹1,676.21 Cr ₹0 -₹15.4 Cr
Profit Before Tax -₹7.37 Cr -₹7.95 Cr ₹1.48 Cr ₹12.8 Cr ₹1,448.82 Cr -₹144.32 Cr -₹171.55 Cr
Total Tax Expense -₹21 Lakh ₹77 Lakh ₹2.98 Cr ₹46.55 Cr ₹370.91 Cr ₹1.96 Cr ₹16.64 Cr
Net Profit -₹7.16 Cr -₹8.72 Cr -₹1.5 Cr -₹33.75 Cr ₹1,077.91 Cr -₹147.65 Cr -₹194.29 Cr
  attributable to Owners -₹5.37 Cr -₹8.37 Cr -₹1.17 Cr ₹0 - - -
  attributable to NCI -₹1.79 Cr -₹35 Lakh -₹33 Lakh ₹0 - - -
Other Comprehensive Income ₹5.42 Cr ₹1.11 Cr -₹39 Lakh ₹28 Lakh -₹40 Lakh ₹82 Lakh ₹2.75 Cr
Total Comprehensive Income -₹1.74 Cr -₹7.61 Cr -₹1.89 Cr -₹33.47 Cr ₹1,077.51 Cr -₹146.83 Cr -₹191.54 Cr
EBITDA (computed) ₹12.24 Cr -₹5.25 Cr ₹5.74 Cr -₹46.3 Cr -₹2.89 Cr ₹86.62 Cr ₹61.05 Cr
Basic EPS ₹-0.88 ₹-1.37 ₹-0.19 ₹-5.51 ₹175.98 ₹-23.87 ₹-30.67
Diluted EPS ₹-0.88 ₹-1.37 ₹-0.19 ₹-5.51 ₹175.98 ₹-23.87 ₹-30.67
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹1,262.17 Cr ₹1,289.75 Cr ₹1,240.68 Cr ₹1,271.16 Cr
Non-current Assets ₹749.13 Cr ₹744.57 Cr ₹755.51 Cr ₹702.85 Cr
Current Assets ₹513.04 Cr ₹545.18 Cr ₹485.17 Cr ₹562.31 Cr
Property, Plant & Equipment ₹553.27 Cr ₹543.39 Cr ₹560.04 Cr ₹588.33 Cr
Inventories ₹192.79 Cr ₹213.67 Cr ₹177.94 Cr ₹202.09 Cr
Trade Receivables ₹73.52 Cr ₹72.56 Cr ₹57.42 Cr ₹60.09 Cr
Cash & Equivalents ₹57.31 Cr ₹82.13 Cr ₹47.17 Cr ₹39.85 Cr
Equity (Net Worth) ₹828.88 Cr ₹830.62 Cr ₹838.23 Cr ₹840.11 Cr
Equity Share Capital ₹6.13 Cr ₹6.13 Cr ₹6.13 Cr ₹6.13 Cr
Borrowings (Non-current) ₹23.66 Cr ₹22.21 Cr ₹20.99 Cr ₹20.16 Cr
Borrowings (Current) ₹0 ₹0 ₹0 ₹6 Lakh
Total Debt (computed) ₹23.66 Cr ₹22.21 Cr ₹20.99 Cr ₹20.22 Cr
Current Liabilities ₹348.68 Cr ₹366.99 Cr ₹308.83 Cr ₹329.73 Cr
Total Liabilities ₹433.29 Cr ₹459.13 Cr ₹402.45 Cr ₹431.05 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹16.68 Cr -₹27.37 Cr -₹10 Lakh -₹423.46 Cr -₹108.43 Cr
Investing Cash Flow -₹40.49 Cr ₹64.98 Cr ₹10.23 Cr ₹430.33 Cr ₹1,282.57 Cr
Financing Cash Flow -₹1.05 Cr -₹2.66 Cr -₹2.81 Cr -₹18.38 Cr -₹1,175.85 Cr
Capital Expenditure ₹54.09 Cr ₹50.31 Cr ₹77.72 Cr ₹40.95 Cr ₹12.51 Cr
Free Cash Flow (computed) -₹37.41 Cr -₹77.68 Cr -₹77.82 Cr -₹464.41 Cr -₹120.94 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹24.82 Cr ₹34.96 Cr ₹7.32 Cr -₹10.5 Cr -₹1.73 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹166.75 Cr ₹165.19 Cr ₹141.13 Cr ₹166.7 Cr ₹132.53 Cr ₹163.49 Cr ₹147.35 Cr ₹115.72 Cr ₹136.46 Cr ₹150.5 Cr ₹143.02 Cr ₹129.19 Cr
Other Income ₹2.55 Cr ₹2.28 Cr ₹6.4 Cr ₹5.67 Cr ₹8.59 Cr ₹3.62 Cr ₹4.65 Cr ₹3.8 Cr ₹10.81 Cr ₹5.68 Cr ₹3.23 Cr ₹6.08 Cr
Total Income ₹169.3 Cr ₹167.47 Cr ₹147.53 Cr ₹172.37 Cr ₹141.12 Cr ₹167.11 Cr ₹152 Cr ₹119.52 Cr ₹147.27 Cr ₹156.18 Cr ₹146.25 Cr ₹135.27 Cr
Cost of Materials Consumed ₹80.78 Cr ₹90.17 Cr ₹46.58 Cr ₹72.71 Cr ₹83.32 Cr ₹48.74 Cr ₹41.77 Cr ₹40.24 Cr ₹45.53 Cr ₹47.83 Cr ₹59.78 Cr ₹57.32 Cr
Purchases of Stock-in-Trade ₹2.67 Cr ₹2.38 Cr ₹1.91 Cr ₹2.01 Cr ₹7.45 Cr ₹15 Lakh ₹0 ₹0 -₹49 Lakh ₹1.09 Cr ₹0 ₹1.2 Cr
Changes in Inventories -₹7.06 Cr -₹24.62 Cr ₹10.45 Cr ₹2.5 Cr -₹38.69 Cr ₹13.66 Cr ₹1.42 Cr ₹1.48 Cr ₹4.71 Cr ₹18.4 Cr -₹1.59 Cr -₹3.66 Cr
Employee Benefit Expense ₹46.82 Cr ₹40.53 Cr ₹47.71 Cr ₹45.72 Cr ₹49.13 Cr ₹42.98 Cr ₹43.44 Cr ₹37.5 Cr ₹38.43 Cr ₹37.65 Cr ₹37.52 Cr ₹35.97 Cr
Finance Costs ₹1.2 Cr ₹1.85 Cr ₹2.14 Cr ₹86 Lakh ₹1.04 Cr ₹99 Lakh ₹98 Lakh ₹87 Lakh ₹82 Lakh ₹85 Lakh ₹91 Lakh ₹1 Cr
Depreciation & Amortisation ₹7.88 Cr ₹8.45 Cr ₹8.34 Cr ₹8.39 Cr ₹8.42 Cr ₹8.98 Cr ₹8.68 Cr ₹8.73 Cr ₹8.81 Cr ₹9.11 Cr ₹9.31 Cr ₹9.48 Cr
Other Expenses ₹40.97 Cr ₹44.99 Cr ₹52.27 Cr ₹44.94 Cr ₹58.2 Cr ₹50 Cr ₹53.72 Cr ₹50.49 Cr ₹54.32 Cr ₹45.68 Cr ₹50.87 Cr ₹48.67 Cr
Total Expenses ₹173.26 Cr ₹163.75 Cr ₹169.4 Cr ₹177.13 Cr ₹168.87 Cr ₹165.5 Cr ₹150.01 Cr ₹139.31 Cr ₹152.13 Cr ₹160.61 Cr ₹156.8 Cr ₹149.98 Cr
Profit Before Exceptional Items & Tax -₹3.96 Cr ₹3.72 Cr -₹21.87 Cr -₹4.76 Cr -₹27.75 Cr ₹1.61 Cr ₹1.99 Cr -₹19.79 Cr -₹4.86 Cr -₹4.43 Cr -₹10.55 Cr -₹14.71 Cr
Exceptional Items ₹2.71 Cr ₹2.77 Cr ₹2.7 Cr ₹11.32 Cr ₹27.71 Cr ₹2.77 Cr ₹2.77 Cr ₹2.74 Cr ₹2.74 Cr ₹2.78 Cr ₹2.77 Cr ₹27.74 Cr
Profit Before Tax -₹1.25 Cr ₹6.49 Cr -₹19.17 Cr ₹6.56 Cr -₹4 Lakh ₹4.38 Cr ₹4.76 Cr -₹17.05 Cr -₹2.12 Cr -₹1.65 Cr -₹7.78 Cr ₹13.03 Cr
Total Tax Expense -₹25 Lakh ₹2.6 Cr -₹5.16 Cr ₹2.6 Cr ₹1.95 Cr -₹6 Lakh ₹5 Lakh -₹1.17 Cr -₹13 Lakh ₹55 Lakh ₹51 Lakh ₹2.05 Cr
Net Profit -₹1 Cr ₹3.89 Cr -₹14.01 Cr ₹3.96 Cr -₹1.99 Cr ₹4.44 Cr ₹4.71 Cr -₹15.88 Cr -₹1.99 Cr -₹2.2 Cr -₹8.29 Cr ₹10.98 Cr
  attributable to Owners ₹52 Lakh ₹3.98 Cr -₹13.92 Cr ₹4.05 Cr -₹1.89 Cr ₹4.52 Cr ₹4.8 Cr -₹15.8 Cr -₹1.43 Cr - ₹0 -
  attributable to NCI -₹1.52 Cr -₹9 Lakh -₹9 Lakh -₹9 Lakh -₹10 Lakh -₹8 Lakh -₹9 Lakh -₹8 Lakh -₹56 Lakh - ₹0 -
Other Comprehensive Income ₹4.99 Cr ₹46 Lakh -₹1 Lakh -₹2 Lakh ₹1.36 Cr -₹8 Lakh -₹20 Lakh ₹3 Lakh -₹69 Lakh ₹9 Lakh ₹11 Lakh ₹10 Lakh
Total Comprehensive Income ₹3.99 Cr ₹4.35 Cr -₹14.02 Cr ₹3.94 Cr -₹63 Lakh ₹4.36 Cr ₹4.51 Cr -₹15.85 Cr -₹2.68 Cr -₹2.11 Cr -₹8.18 Cr ₹11.08 Cr
EBITDA (computed) ₹5.12 Cr ₹14.02 Cr -₹11.39 Cr ₹4.49 Cr -₹18.29 Cr ₹11.58 Cr ₹11.65 Cr -₹10.19 Cr ₹4.77 Cr ₹5.53 Cr -₹33 Lakh -₹4.23 Cr
Basic EPS ₹0.08 ₹0.65 ₹-2.27 ₹0.66 ₹-0.31 ₹0.74 ₹0.77 ₹-2.59 ₹-0.23 ₹-0.37 ₹-1.35 ₹1.79
Diluted EPS ₹0.08 ₹0.65 ₹-2.27 ₹0.66 ₹-0.31 ₹0.74 ₹0.77 ₹-2.59 ₹-0.23 ₹-0.37 ₹-1.35 ₹1.79
Latest 12 quarters shown of 25 on record.
Segment · Q4 FY26 (latest quarter) Revenue Result (PBIT) Assets Liabilities
Vaccines ₹107.95 Cr -₹3.45 Cr ₹870.14 Cr ₹302.02 Cr
Formulations ₹58.8 Cr ₹2.2 Cr ₹392.03 Cr ₹131.27 Cr
Segment · FY 2026 (annual) Revenue Result (PBIT) Assets Liabilities
Vaccines ₹410.25 Cr -₹26.84 Cr - -
Formulations ₹229.52 Cr ₹19.47 Cr - -
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹413.49 Cr ₹309.85 Cr ₹359.6 Cr ₹257.07 Cr ₹235.5 Cr ₹343.56 Cr ₹158.09 Cr
Other Income ₹18 Cr ₹16.62 Cr ₹24.91 Cr ₹34.43 Cr ₹12.57 Cr ₹20.74 Cr ₹30.87 Cr
Total Income ₹431.49 Cr ₹326.47 Cr ₹384.51 Cr ₹291.5 Cr ₹248.07 Cr ₹364.3 Cr ₹188.96 Cr
Cost of Materials Consumed ₹219.49 Cr ₹124.01 Cr ₹123.9 Cr ₹131.16 Cr ₹172.4 Cr ₹68.7 Cr ₹75.27 Cr
Purchases of Stock-in-Trade ₹4.01 Cr ₹1.75 Cr ₹0 ₹75 Lakh ₹64 Lakh ₹93.32 Cr ₹11.44 Cr
Changes in Inventories -₹12.42 Cr -₹23.06 Cr ₹17.79 Cr ₹31.15 Cr -₹60.95 Cr ₹14.24 Cr -₹28.18 Cr
Employee Benefit Expense ₹100.33 Cr ₹97.02 Cr ₹86.53 Cr ₹71.03 Cr ₹72.5 Cr ₹59.47 Cr ₹46.64 Cr
Finance Costs ₹25.3 Cr ₹15.46 Cr ₹13.78 Cr ₹10.06 Cr ₹7.04 Cr ₹7.52 Cr ₹5.27 Cr
Depreciation & Amortisation ₹18.75 Cr ₹20.29 Cr ₹21.09 Cr ₹24.5 Cr ₹26.43 Cr ₹26.57 Cr ₹26.91 Cr
Other Expenses ₹119.88 Cr ₹117.06 Cr ₹117.21 Cr ₹85.6 Cr ₹123.59 Cr ₹107.33 Cr ₹115.14 Cr
Total Expenses ₹475.34 Cr ₹352.53 Cr ₹380.3 Cr ₹354.25 Cr ₹341.65 Cr ₹377.15 Cr ₹252.49 Cr
Profit Before Exceptional Items & Tax -₹43.85 Cr -₹26.06 Cr ₹4.21 Cr -₹62.75 Cr -₹93.58 Cr -₹12.85 Cr -₹63.53 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 -₹15.4 Cr
Profit Before Tax -₹43.85 Cr -₹26.06 Cr ₹4.21 Cr -₹62.75 Cr -₹93.58 Cr -₹12.85 Cr -₹78.93 Cr
Total Tax Expense -₹13.97 Cr -₹10.83 Cr ₹66 Lakh ₹24.79 Cr ₹0 ₹1.56 Cr ₹17.1 Cr
Net Profit -₹29.88 Cr -₹15.23 Cr ₹3.55 Cr -₹87.54 Cr -₹93.58 Cr -₹14.44 Cr -₹153.08 Cr
Other Comprehensive Income ₹1.14 Cr ₹5 Lakh -₹6 Lakh -₹1.9 Cr ₹50 Lakh ₹1.38 Cr ₹1.23 Cr
Total Comprehensive Income -₹28.74 Cr -₹15.18 Cr ₹3.49 Cr -₹89.44 Cr -₹93.08 Cr -₹13.06 Cr -₹151.85 Cr
EBITDA (computed) ₹20 Lakh ₹9.69 Cr ₹39.08 Cr -₹28.19 Cr -₹60.11 Cr ₹21.24 Cr -₹31.35 Cr
Basic EPS ₹-4.88 ₹-2.49 ₹0.58 ₹-14.29 ₹-15.28 ₹-2.35 ₹-15.68
Diluted EPS ₹4.88 ₹-2.49 ₹0.58 ₹-14.29 ₹-15.28 ₹0.00 ₹-15.68
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹852.42 Cr ₹869.47 Cr ₹753.64 Cr ₹723.91 Cr
Non-current Assets ₹567.93 Cr ₹575.74 Cr ₹570.44 Cr ₹518.77 Cr
Current Assets ₹284.49 Cr ₹293.73 Cr ₹183.2 Cr ₹199.14 Cr
Property, Plant & Equipment ₹347.39 Cr ₹347.5 Cr ₹357.22 Cr ₹385.26 Cr
Inventories ₹126.34 Cr ₹152.1 Cr ₹107.93 Cr ₹116.1 Cr
Trade Receivables ₹30.68 Cr ₹20.85 Cr ₹11.08 Cr ₹12.27 Cr
Cash & Equivalents ₹2.41 Cr ₹38.5 Cr ₹5.09 Cr ₹6.01 Cr
Equity (Net Worth) ₹285.24 Cr ₹313.97 Cr ₹329.15 Cr ₹325.66 Cr
Equity Share Capital ₹6.13 Cr ₹6.13 Cr ₹6.13 Cr ₹6.13 Cr
Borrowings (Non-current) ₹245.94 Cr ₹160.51 Cr ₹124.87 Cr ₹102.4 Cr
Borrowings (Current) ₹19.18 Cr ₹67.94 Cr ₹0 ₹6 Lakh
Total Debt (computed) ₹265.12 Cr ₹228.45 Cr ₹124.87 Cr ₹102.46 Cr
Current Liabilities ₹285.19 Cr ₹351.41 Cr ₹248.98 Cr ₹250.85 Cr
Total Liabilities ₹567.18 Cr ₹555.5 Cr ₹424.49 Cr ₹398.25 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow -₹40.15 Cr ₹3.94 Cr ₹37.27 Cr -₹10.74 Cr -₹52.7 Cr
Investing Cash Flow -₹18.53 Cr -₹60.6 Cr -₹51.01 Cr ₹2.4 Cr ₹39.54 Cr
Financing Cash Flow ₹22.54 Cr ₹90.07 Cr ₹12.82 Cr ₹9.02 Cr ₹9.83 Cr
Capital Expenditure ₹33.73 Cr ₹52.97 Cr ₹75.03 Cr ₹38.38 Cr ₹8.05 Cr
Free Cash Flow (computed) -₹73.88 Cr -₹49.03 Cr -₹37.76 Cr -₹49.12 Cr -₹60.75 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹36.09 Cr ₹33.41 Cr -₹92 Lakh ₹68 Lakh -₹3.33 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹111.12 Cr ₹99.31 Cr ₹90.81 Cr ₹112.25 Cr ₹67.9 Cr ₹108.43 Cr ₹76.64 Cr ₹56.88 Cr ₹80.37 Cr ₹95.23 Cr ₹94.59 Cr ₹89.41 Cr
Other Income ₹5.6 Cr ₹3.84 Cr ₹3.61 Cr ₹4.95 Cr ₹6.09 Cr ₹3.32 Cr ₹3.41 Cr ₹3.8 Cr ₹16.39 Cr ₹3.05 Cr ₹2.13 Cr ₹3.34 Cr
Total Income ₹116.72 Cr ₹103.15 Cr ₹94.42 Cr ₹117.2 Cr ₹73.99 Cr ₹111.75 Cr ₹80.05 Cr ₹60.68 Cr ₹96.76 Cr ₹98.28 Cr ₹96.72 Cr ₹92.75 Cr
Cost of Materials Consumed ₹58.79 Cr ₹72.88 Cr ₹26.88 Cr ₹60.94 Cr ₹59.37 Cr ₹28.16 Cr ₹22.04 Cr ₹14.44 Cr ₹26.09 Cr ₹23.56 Cr ₹37.09 Cr ₹37.16 Cr
Purchases of Stock-in-Trade ₹1 Lakh ₹2.08 Cr ₹78 Lakh ₹1.14 Cr ₹1.75 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹2.99 Cr -₹27.23 Cr ₹17.74 Cr ₹6 Lakh -₹34.1 Cr ₹10.15 Cr -₹4.33 Cr ₹5.22 Cr ₹94 Lakh ₹20.3 Cr -₹95 Lakh -₹2.5 Cr
Employee Benefit Expense ₹22.76 Cr ₹25.16 Cr ₹27.04 Cr ₹25.37 Cr ₹27.26 Cr ₹23.78 Cr ₹24.45 Cr ₹21.53 Cr ₹23.29 Cr ₹20.84 Cr ₹22.29 Cr ₹20.11 Cr
Finance Costs ₹6.33 Cr ₹7.04 Cr ₹5.93 Cr ₹6 Cr ₹4.64 Cr ₹3.85 Cr ₹3.76 Cr ₹3.21 Cr ₹3.36 Cr ₹3.41 Cr ₹3.55 Cr ₹3.46 Cr
Depreciation & Amortisation ₹4.18 Cr ₹4.89 Cr ₹4.91 Cr ₹4.77 Cr ₹4.91 Cr ₹5.21 Cr ₹5.09 Cr ₹5.08 Cr ₹5.14 Cr ₹5.21 Cr ₹5.34 Cr ₹5.4 Cr
Other Expenses ₹32.25 Cr ₹27.8 Cr ₹32.07 Cr ₹27.76 Cr ₹32.19 Cr ₹30.95 Cr ₹27.74 Cr ₹26.18 Cr ₹39.29 Cr ₹23.89 Cr ₹26.2 Cr ₹27.83 Cr
Total Expenses ₹121.33 Cr ₹112.62 Cr ₹115.35 Cr ₹126.04 Cr ₹96.02 Cr ₹102.1 Cr ₹78.75 Cr ₹75.66 Cr ₹98.11 Cr ₹97.21 Cr ₹93.52 Cr ₹91.46 Cr
Profit Before Exceptional Items & Tax -₹4.61 Cr -₹9.47 Cr -₹20.93 Cr -₹8.84 Cr -₹22.03 Cr ₹9.65 Cr ₹1.3 Cr -₹14.98 Cr -₹1.35 Cr ₹1.07 Cr ₹3.2 Cr ₹1.29 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax -₹4.61 Cr -₹9.47 Cr -₹20.93 Cr -₹8.84 Cr -₹22.03 Cr ₹9.65 Cr ₹1.3 Cr -₹14.98 Cr -₹1.35 Cr ₹1.07 Cr ₹3.2 Cr ₹1.29 Cr
Total Tax Expense -₹4.43 Cr -₹2.11 Cr -₹5.29 Cr -₹2.14 Cr -₹9.64 Cr ₹0 ₹1 Lakh -₹1.2 Cr ₹2 Lakh ₹64 Lakh ₹0 ₹0
Net Profit -₹18 Lakh -₹7.36 Cr -₹15.64 Cr -₹6.7 Cr -₹12.39 Cr ₹9.65 Cr ₹1.29 Cr -₹13.78 Cr -₹1.37 Cr ₹43 Lakh ₹3.2 Cr ₹1.29 Cr
Other Comprehensive Income ₹77 Lakh ₹34 Lakh ₹1 Lakh ₹2 Lakh ₹10 Lakh -₹2 Lakh -₹3 Lakh ₹0 -₹6 Lakh ₹0 ₹0 ₹0
Total Comprehensive Income ₹59 Lakh -₹7.02 Cr -₹15.63 Cr -₹6.68 Cr -₹12.29 Cr ₹9.63 Cr ₹1.26 Cr -₹13.78 Cr -₹1.43 Cr ₹43 Lakh ₹3.2 Cr ₹1.29 Cr
EBITDA (computed) ₹5.9 Cr ₹2.46 Cr -₹10.09 Cr ₹1.93 Cr -₹12.48 Cr ₹18.71 Cr ₹10.15 Cr -₹6.69 Cr ₹7.15 Cr ₹9.69 Cr ₹12.09 Cr ₹10.15 Cr
Basic EPS ₹-0.03 ₹-1.20 ₹-2.55 ₹-1.09 ₹-2.02 ₹1.58 ₹0.21 ₹-2.25 ₹-0.22 ₹0.07 ₹0.52 ₹0.21
Diluted EPS ₹-0.03 ₹-1.20 ₹-2.55 ₹-1.09 ₹-2.02 ₹1.58 ₹0.21 ₹-2.25 ₹-0.22 ₹0.07 ₹0.52 ₹0.21
Latest 12 quarters shown of 25 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Panacea Biotec Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Panacea Biotec Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 72.48%, foreign institutional investors hold 1.60%, domestic institutional investors hold 1.97%, retail and other public shareholders hold 23.96% of Panacea Biotec Limited. The company had 32,620 shareholders on record.

Promoters: 72.48%DII (Domestic Institutional): 1.97%FII (Foreign Institutional): 1.60%Retail & Others: 23.96%
Mar 2026
QUARTER
72.48% Promoters
1.97% DII (Domestic Institutional)
1.60% FII (Foreign Institutional)
23.96% Retail & Others
Promoter holding - history
Now 72.48% · Mar 2026High 74.65% · Mar 2016Low 72.48% · Mar 2025
71%72.3%73.5%74.8%76%Dec 2015Jun 2018Dec 2020Jun 2023Dec 2025Dec 2015: 74.47%Mar 2016: 74.65%Jun 2016: 74.62%Sep 2016: 74.60%Dec 2016: 74.60%Mar 2017: 74.60%Jun 2017: 74.60%Sep 2017: 74.60%Dec 2017: 74.07%Mar 2018: 74.07%Jun 2018: 74.07%Sep 2018: 73.59%Dec 2018: 73.59%Mar 2019: 73.59%Jun 2019: 73.59%Sep 2019: 73.59%Dec 2019: 73.59%Mar 2020: 73.59%Jun 2020: 73.59%Sep 2020: 73.59%Dec 2020: 73.59%Mar 2021: 73.59%Jun 2021: 73.59%Sep 2021: 73.59%Dec 2021: 73.59%Mar 2022: 73.59%Jun 2022: 73.59%Sep 2022: 73.59%Dec 2022: 73.59%Mar 2023: 73.59%Jun 2023: 73.59%Sep 2023: 73.59%Dec 2023: 73.59%Mar 2024: 73.59%Jun 2024: 73.46%Sep 2024: 72.87%Dec 2024: 72.49%Mar 2025: 72.48%Jun 2025: 72.48%Sep 2025: 72.48%Dec 2025: 72.48%Mar 2026: 72.48%74.65%72.48%72.48%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters72.48%72.48%72.48%72.48%72.48%72.49%
Public27.52%27.52%27.52%27.52%27.52%27.51%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters72.48%72.48%73.59%73.59%73.59%73.59%73.59%73.59%74.07%74.60%74.65%
Public27.52%27.52%26.41%26.41%26.41%26.41%26.41%26.41%25.93%25.40%25.35%
Promoter change (YoY, %pts)+0.00-1.11+0.00+0.00+0.00+0.00+0.00-0.48-0.53-0.05-

Board & Governance of Panacea Biotec Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Panacea Biotec Limited has 11 directors - 6 independent and 5 executive. The board is chaired by Rajesh Jain.

DirectorPositionOn board sinceListed boards
Rajesh Jain Executive Director · MD · Chairperson 1984-11-15 1
Sandeep Jain Executive Director 1984-11-15 1
Ankesh Jain Executive Director 2016-04-01 1
Harshet Jain Executive Director 2025-02-14 1
Sanjay Trehan Executive Director 2025-02-14 1
Mukul Gupta Non-Executive - Independent Director 2016-04-01 1
Ambika Sharma Non-Executive - Independent Director 2024-02-14 6
Rajesh Jain Non-Executive - Independent Director 2024-11-13 3
Krishan Kumar Jalan Non-Executive - Independent Director 2025-02-14 5
Rajender Pal Singh Non-Executive - Independent Director 2025-02-14 2
Venkatesh Sarvasiddhi Non-Executive - Independent Director 2025-02-14 1
Board Committees
CommitteeMembers
Audit Committee Mukul Gupta (Chairperson), Rajesh Jain (Chairperson), Ambika Sharma, Krishan Kumar Jalan
Nomination and remuneration committee Ambika Sharma (Chairperson), Mukul Gupta, Rajesh Jain, Rajender Pal Singh
Stakeholders Relationship Committee Ambika Sharma (Chairperson), Sanjay Trehan, Sandeep Jain
Risk Management Committee Rajesh Jain (Chairperson), Sandeep Jain, Ankesh Jain, Mukul Gupta, Sanjay Trehan, Rajesh Jain, Rajender Pal Singh

Group Structure of Panacea Biotec Limited

Panacea Biotec Limited has 2 subsidiary companies, 1 joint venture, and 1 associated company. This group structure data is as of FY 2024. The corporate group structure reflects Panacea Biotec Limited's business expansion strategy and organizational complexity.

2
Subsidiary companies
1
Joint ventures
1
Associated companies
Key Subsidiaries
Company Name CIN Shares Held
Panacea Biotec Pharma Limited U24299DL2019PLC347566 -
Meyten Realtech Private Limited U70109PB2019PTC049328 -

Showing major subsidiaries. Total: 2.

Charges & Borrowings of Panacea Biotec Limited

Open charges
₹739.69 Cr
Satisfied charges
₹3,545.32 Cr
Breakdown by lending institutions
Others₹739.69 Cr
Latest charge details
DateLenderAmountStatus
06 Apr 2019 Others ₹739.69 Cr Open
05 Jan 2022 Axis Bank Limited ₹29.61 Lakh Satisfied
04 Feb 2020 Others ₹754.44 Cr Satisfied
14 Nov 2017 Others ₹5.29 Cr Satisfied
27 Dec 2014 Sbicap Trustee Company Limited ₹934.27 Cr Satisfied

Total charge records: 39 View all charges

Employees and EPFO Compliance at Panacea Biotec Limited

Panacea Biotec Limited has a workforce of 1,173 employees as of Mar 08, 2025.

Employee count
1,173
Active EPFO establishments
1
Employee growth
4.08%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Panacea Biotec Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Panacea Biotec Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Panacea Biotec Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Panacea Biotec Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Panacea Biotec Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Panacea Biotec Limited

MSME Payment Delays by Panacea Biotec Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Panacea Biotec Limited

Subsidiaries & Group Companies of Panacea Biotec Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Panacea Biotec Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Panacea Biotec Limited

MCA Filings & Documents of Panacea Biotec Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Panacea Biotec Limited

Directors
16 Dec 2025
Vinod Goel was appointed as a CFO on 16 Dec 2025 & has been associated with this company since 6 months 23 days.
Directors
14 Feb 2025
Harshet Jain was appointed as a Whole-time director on 14 Feb 2025 & has been associated with this company since 1 year 4 months.
Directors
14 Feb 2025
Rajender Pal Singh was appointed as a Director on 14 Feb 2025 & has been associated with this company since 1 year 4 months.
Directors
14 Feb 2025
Venkatesh Sarvasiddhi was appointed as a Director on 14 Feb 2025 & has been associated with this company since 1 year 4 months.
Directors
14 Feb 2025
Krishan Kumar Jalan was appointed as a Director on 14 Feb 2025 & has been associated with this company since 1 year 4 months.
Activity
27 Sep 2024
Panacea Biotec Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records.

Recent News on Panacea Biotec Limited

Mankind Pharma sharpens its focus on specialty products
20 Oct 2024 · Thehindubusinessline

Frequently Asked Questions about Panacea Biotec Limited

Panacea Biotec Limited is an active public limited company in the life sciences sector based in Lalru, Punjab, India. It was incorporated on 02 February 1984 (42+ years old) and is registered under CIN L33117PB1984PLC022350. Listed on BSE: 531349 and NSE: PANACEABIO. The company has 1,173 employees.

Panacea Biotec Limited reported revenue of ₹384.51 Cr for FY 2024 (up 31.91% YoY).

The current directors of Panacea Biotec Limited are:

The primary industry of Panacea Biotec Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.

Yes. Panacea Biotec Limited is listed on both BSE (code: 531349) and NSE (symbol: PANACEABIO).

Panacea Biotec Limited can be reached at the registered office: Ambala – Chandigarh Highway, Lalru, Punjab, India – 140501, or through the website panaceabiotec.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available